{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:35:21Z","timestamp":1779370521478,"version":"3.53.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10549-017-4217-5","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T16:51:16Z","timestamp":1490633476000},"page":"573-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer"],"prefix":"10.1007","volume":"163","author":[{"given":"Yaeji","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sook","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boo-Kyung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"issue":"1","key":"4217_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/radiology.203.1.9122383","volume":"203","author":"M Muller-Schimpfle","year":"1997","unstructured":"Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen C (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203(1):145\u2013149","journal-title":"Radiology"},{"issue":"1","key":"4217_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiology.203.1.9122382","volume":"203","author":"CK Kuhl","year":"1997","unstructured":"Kuhl CK, Bieling HB, Gieseke J, Kreft BP, Sommer T, Lultterbey G et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical phase dependency. Radiology 203(1):137\u2013144","journal-title":"Radiology"},{"issue":"3","key":"4217_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004728-199905000-00015","volume":"23","author":"JR Reichenbach","year":"1999","unstructured":"Reichenbach JR, Przetak C, Klinger G, Kaiser WA (1999) Assessment of breast tissue changes on hormonal replacement therapy using MRI: a pilot study. J Comput Assist Tomogr 23(3):407\u2013413","journal-title":"J Comput Assist Tomogr"},{"issue":"1","key":"4217_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1148\/radiol.2351040012","volume":"235","author":"JP Delille","year":"2005","unstructured":"Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Garrido L (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging\u2014initial observations. Radiology 235(1):36\u201341","journal-title":"Radiology"},{"issue":"11","key":"4217_CR5","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U","volume":"67","author":"AF Saftlas","year":"1991","unstructured":"Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M et al (1991) Mammographic densities and risk of breast cancer. Cancer 67(11):2833\u20132838","journal-title":"Cancer"},{"issue":"9","key":"4217_CR6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","volume":"87","author":"NF Boyd","year":"1995","unstructured":"Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB et al (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87(9):670\u2013675","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4217_CR7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2214\/AJR.10.4550","volume":"196","author":"NM Hambly","year":"2011","unstructured":"Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011) Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR 196(1):218\u2013224","journal-title":"AJR"},{"issue":"4","key":"4217_CR8","doi-asserted-by":"crossref","first-page":"W373","DOI":"10.2214\/AJR.10.6272","volume":"198","author":"WB DeMartini","year":"2012","unstructured":"DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD (2012) Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR 198(4):W373\u2013W380","journal-title":"AJR"},{"issue":"1","key":"4217_CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","volume":"260","author":"V King","year":"2011","unstructured":"King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260(1):50\u201360","journal-title":"Radiology"},{"issue":"11","key":"4217_CR10","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00330-011-2175-6","volume":"21","author":"T Uematsu","year":"2011","unstructured":"Uematsu T, Kasami M, Watanabe J (2011) Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer? Eur Radiol 21(11):2261\u20132267","journal-title":"Eur Radiol"},{"issue":"9","key":"4217_CR11","doi-asserted-by":"crossref","first-page":"e3000","DOI":"10.1097\/MD.0000000000003000","volume":"95","author":"JS Choi","year":"2016","unstructured":"Choi JS, Ko ES, Ko EY, Han BK, Nam SJ (2016) Background parenchymal enhancement on preoperative magnetic resonance imaging: association with recurrence-free survival in breast cancer patients treated with neoadjuvant chemotherapy. Medicine (Baltimore) 95(9):e3000","journal-title":"Medicine (Baltimore)"},{"key":"4217_CR12","doi-asserted-by":"crossref","unstructured":"Morris EA, Comstock CE, Lee CH, et al. (2013) ACR BI-RADS magnetic resonance imaging. In: ACR BI-RADS Atlas, breast imaging reporting and data system. American College of Radiology, Reston.","DOI":"10.1016\/j.mric.2013.04.006"},{"issue":"1","key":"4217_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-013-2407-3","volume":"138","author":"JH Youk","year":"2013","unstructured":"Youk JH, Gweon HM, Son EJ, Kim JA, Jeong J (2013) Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile. Breast Cancer Res Treat 138(1):119\u2013126","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4217_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174","journal-title":"Biometrics"},{"issue":"1 Pt 1","key":"4217_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9378(97)80024-5","volume":"176","author":"G S\u00f6derqvist","year":"1997","unstructured":"S\u00f6derqvist G, Isaksson E, von Schoultz B, Carlstrom K, Tani E, Skoog L (1997) Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 176(1 Pt 1):123\u2013128","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"4217_CR16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejrad.2010.07.019","volume":"80","author":"ES Ko","year":"2011","unstructured":"Ko ES, Lee BH, Choi HY, Kim RB, Noh WC (2011) Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound. Eur J Radiol 80(3):719\u2013723","journal-title":"Eur J Radiol"},{"issue":"3","key":"4217_CR17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11547-010-0513-4","volume":"115","author":"R Cubuk","year":"2010","unstructured":"Cubuk R, Tasali N, Narin B, Keskiner F, Celik L, Guney S (2010) Correlation between breast density in mammography and background enhancement in MR mammography. Radiol Med (Torino) 115(3):434\u2013441","journal-title":"Radiol Med (Torino)"},{"issue":"1","key":"4217_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiol.2016160284","volume":"282","author":"J Sogani","year":"2017","unstructured":"Sogani J, Morris EA, Kaplan JB, D\u2019Alessio D, Goldman D, Moskowitz CS et al (2017) Comparison of background parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging. Radiology 282(1):63\u201373","journal-title":"Radiology"},{"issue":"26","key":"4217_CR19","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","volume":"333","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333(26):1757\u20131763","journal-title":"N Engl J Med"},{"issue":"11","key":"4217_CR20","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.cellsig.2014.07.035","volume":"26","author":"K Bhatelia","year":"2014","unstructured":"Bhatelia K, Singh K, Singh R (2014) TLRs: linking inflammation and breast cancer. Cell Signal 26(11):2350\u20132357","journal-title":"Cell Signal"},{"issue":"2","key":"4217_CR21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","volume":"276","author":"BN Dontchos","year":"2015","unstructured":"Dontchos BN, Rahbar H, Partridge SC et al (2015) Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk? Radiology 276(2):371\u2013380","journal-title":"Radiology"},{"issue":"1","key":"4217_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","volume":"76","author":"WF Anderson","year":"2002","unstructured":"Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database. Breast Cancer Res Treat 76(1):27\u201336","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"4217_CR23","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(17)38062-6","volume":"253","author":"KB Horwitz","year":"1978","unstructured":"Horwitz KB, McGuire WL (1978) Estrogen control progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J Biol Chem 253(7):2223\u20132228","journal-title":"J Biol Chem"},{"issue":"3","key":"4217_CR24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bjc.2013.756","volume":"110","author":"CA Purdie","year":"2014","unstructured":"Purdie CA, Quinlan P, Jordan LB et al (2014) Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. Br J Cancer 110(3):565\u2013572","journal-title":"Br J Cancer"},{"issue":"7","key":"4217_CR25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.2007.12.9437","volume":"26","author":"M Dowsett","year":"2008","unstructured":"Dowsett M, Allred C, Knox J et al (2008) Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. J Clin Oncol 26(7):1059\u20131065","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"4217_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(02)00461-5","volume":"188","author":"RT Chatterton Jr","year":"2002","unstructured":"Chatterton RT Jr, Lydon JP, Mehta RG et al (2002) Role of progesterone receptor (PR) in susceptibility of mouse mammary gland to 7, 12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett 188(1\u20132):47\u201352","journal-title":"Cancer Lett"},{"issue":"2","key":"4217_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1025952924864","volume":"8","author":"OM Conneely","year":"2003","unstructured":"Conneely OM, Jericevic BM, Lydon JP (2003) Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 8(2):205\u2013214","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"6","key":"4217_CR28","doi-asserted-by":"crossref","first-page":"e98404","DOI":"10.1371\/journal.pone.0098404","volume":"9","author":"A Kougioumtzi","year":"2014","unstructured":"Kougioumtzi A, Tsaparas P, Magklara A (2014) Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells. PLoS ONE 9(6):e98404","journal-title":"PLoS ONE"},{"issue":"3","key":"4217_CR29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1148\/radiol.13120121","volume":"267","author":"AM Scaranelo","year":"2013","unstructured":"Scaranelo AM, Carrillo MC, Fleming R, Jacks LM, Kulkarni SR, Crystal P (2013) Pilot study of quantitative analysis of background enhancement on breast MR images: association with menstrual cycle and mammographic breast density. Radiology 267(3):692\u2013700","journal-title":"Radiology"},{"issue":"1","key":"4217_CR30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2214\/AJR.13.10952","volume":"203","author":"A Melsaether","year":"2014","unstructured":"Melsaether A, McDermott M, Gupta D, Pysarenko K, Shaylor SD, Moy L (2014) Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training. AJR 203(1):209\u2013215","journal-title":"AJR"},{"issue":"10","key":"4217_CR31","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T Saphner","year":"1996","unstructured":"Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14(10):2738\u20132746","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4217-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T22:54:30Z","timestamp":1658876070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["4217"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4217-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]}}}